Similar articles for PMID: 26585058

Year	Number of Results
1980	1
1987	1
1988	2
1994	1
1997	2
1998	2
1999	2
2000	1
2001	1
2002	3
2003	2
2004	5
2005	8
2006	8
2007	13
2008	12
2009	15
2010	19
2011	18
2012	17
2013	20
2014	18
2015	24
2016	33
2017	38
2018	28
2019	25
2020	21
2021	17
2022	11
2023	5
2024	0

1

Imaging the Impact of the P-Glycoprotein (ABCB1) Function on the Brain Kinetics of Metoclopramide.

Pottier G, Marie S, Goutal S, Auvity S, Peyronneau MA, Stute S, Boisgard R, Dollé F, Buvat I, Caillé F, Tournier N. Pottier G, et al. J Nucl Med. 2016 Feb;57(2):309-14. doi: 10.2967/jnumed.115.164350. Epub 2015 Nov 19. J Nucl Med. 2016. PMID: 26585058 Free article.

2

P-Glycoprotein (ABCB1) Inhibits the Influx and Increases the Efflux of ¹¹C-Metoclopramide Across the Blood-Brain Barrier: A PET Study on Nonhuman Primates.

Auvity S, Caillé F, Marie S, Wimberley C, Bauer M, Langer O, Buvat I, Goutal S, Tournier N. Auvity S, et al. J Nucl Med. 2018 Oct;59(10):1609-1615. doi: 10.2967/jnumed.118.210104. Epub 2018 May 10. J Nucl Med. 2018. PMID: 29748235 Free article.

3

Kinetic analysis of the cooperation of P-glycoprotein (P-gp/Abcb1) and breast cancer resistance protein (Bcrp/Abcg2) in limiting the brain and testis penetration of erlotinib, flavopiridol, and mitoxantrone.

Kodaira H, Kusuhara H, Ushiki J, Fuse E, Sugiyama Y. Kodaira H, et al. J Pharmacol Exp Ther. 2010 Jun;333(3):788-96. doi: 10.1124/jpet.109.162321. Epub 2010 Mar 19. J Pharmacol Exp Ther. 2010. PMID: 20304939

4

Quantitative evaluation of the impact of active efflux by p-glycoprotein and breast cancer resistance protein at the blood-brain barrier on the predictability of the unbound concentrations of drugs in the brain using cerebrospinal fluid concentration as a surrogate.

Kodaira H, Kusuhara H, Fujita T, Ushiki J, Fuse E, Sugiyama Y. Kodaira H, et al. J Pharmacol Exp Ther. 2011 Dec;339(3):935-44. doi: 10.1124/jpet.111.180398. Epub 2011 Sep 20. J Pharmacol Exp Ther. 2011. PMID: 21934030

5

Transport of selected PET radiotracers by human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2): an in vitro screening.

Tournier N, Valette H, Peyronneau MA, Saba W, Goutal S, Kuhnast B, Dollé F, Scherrmann JM, Cisternino S, Bottlaender M. Tournier N, et al. J Nucl Med. 2011 Mar;52(3):415-23. doi: 10.2967/jnumed.110.079608. Epub 2011 Feb 14. J Nucl Med. 2011. PMID: 21321274 Free article.

6

[¹¹C]befloxatone brain kinetics is not influenced by Bcrp function at the blood-brain barrier: a PET study using Bcrp TGEM knockout rats.

Hosten B, Boisgard R, Jacob A, Goutal S, Saubaméa B, Dollé F, Scherrmann JM, Cisternino S, Tournier N. Hosten B, et al. Eur J Pharm Sci. 2013 Nov 20;50(3-4):520-5. doi: 10.1016/j.ejps.2013.08.015. Epub 2013 Aug 24. Eur J Pharm Sci. 2013. PMID: 23981334

7

Impact of P-gp and BCRP on pulmonary drug disposition assessed by PET imaging in rats.

Mairinger S, Hernández-Lozano I, Filip T, Sauberer M, Löbsch M, Stanek J, Wanek T, Sake JA, Pekar T, Ehrhardt C, Langer O. Mairinger S, et al. J Control Release. 2022 Sep;349:109-117. doi: 10.1016/j.jconrel.2022.06.065. Epub 2022 Jul 8. J Control Release. 2022. PMID: 35798092 Free article.

8

Impact of P-Glycoprotein Function on the Brain Kinetics of the Weak Substrate ¹¹C-Metoclopramide Assessed with PET Imaging in Humans.

Tournier N, Bauer M, Pichler V, Nics L, Klebermass EM, Bamminger K, Matzneller P, Weber M, Karch R, Caillé F, Auvity S, Marie S, Jäger W, Wadsak W, Hacker M, Zeitlinger M, Langer O. Tournier N, et al. J Nucl Med. 2019 Jul;60(7):985-991. doi: 10.2967/jnumed.118.219972. Epub 2019 Jan 10. J Nucl Med. 2019. PMID: 30630940 Free PMC article. Clinical Trial.

9

P-glycoprotein and breast cancer resistance protein influence brain distribution of dasatinib.

Chen Y, Agarwal S, Shaik NM, Chen C, Yang Z, Elmquist WF. Chen Y, et al. J Pharmacol Exp Ther. 2009 Sep;330(3):956-63. doi: 10.1124/jpet.109.154781. Epub 2009 Jun 2. J Pharmacol Exp Ther. 2009. PMID: 19491323

10

Brain accumulation of the EML4-ALK inhibitor ceritinib is restricted by P-glycoprotein (P-GP/ABCB1) and breast cancer resistance protein (BCRP/ABCG2).

Kort A, Sparidans RW, Wagenaar E, Beijnen JH, Schinkel AH. Kort A, et al. Pharmacol Res. 2015 Dec;102:200-7. doi: 10.1016/j.phrs.2015.09.003. Epub 2015 Sep 8. Pharmacol Res. 2015. PMID: 26361725

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

320 results

Results by year